• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number ESP100-19
Device Problems Patient-Device Incompatibility (2682); Material Split, Cut or Torn (4008); Central Regurgitation (4068)
Patient Problems Aortic Valve Stenosis (1717); Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 11/01/2023
Event Type  Injury  
Event Description
It was reported that in an unknown date epic stented porcine heart valve was successfully implanted.Due to aortic regurgitation, the valve was removed.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2014, a 19mm epic supra valve was successfully implanted with two-vessel coronary artery bypass grafting for aortic stenosis and coronary artery stenosis.Around 2019, aortic regurgitation (ar) was noted to be mild, and no particular symptoms were observed.On (b)(6) 2022, ar was noted to be mild to moderate.In 2023 (date unknown), symptoms of shortness of breath on exertion appeared and worsened.Upon examination, moderate-severe ar and moderate aortic stenosis (as) (vmax 3.5m/s) were observed.The patient was diagnosed with heart failure due to aortic stenosis and regurgitation.On (b)(6) 2023, the 19mm epic valve was explanted and a 21mm non-abbott valve was implanted.The patient is reported to be stable.It was stated by the physician that in the intraoperative finding, the sclerosis of the leaflets was mild, but the non-coronary cusp was prolapsed.It was thought to be caused by a slight tear of the leaflets.In addition, a slight subvalvular pannus was observed.
 
Manufacturer Narrative
Explant due to shortness of breath on exertion, heart failure due to aortic stenosis and regurgitation was reported.Also reported was that the non-coronary cusp was prolapsed and there was slight sub-valvular pannus.The investigation found all three cusps were torn.There were mild degenerative changes and cusp thinning noted on cusps 1 and 3.No inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of tear could not be conclusively determined.In the absence of any calcification or evidence for infection, the reported event is consistent with a non-calcific leaflet tear.A non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.In this case, histological evaluation did demonstrate degenerative changes at the tear site, which could have contributed to the formation of the tear.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ SUPRA VALVE (AORTIC)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL LTDA. REG#3001883144
1301rua profvieira demendonça
bairro engenho nogueira 31.31 0-26
BR   31.310-260
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18209144
MDR Text Key329003661
Report Number2135147-2023-05180
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2017
Device Catalogue NumberESP100-19
Device Lot Number4489646
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/06/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/02/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention; Hospitalization;
Patient Age75 YR
Patient SexMale
-
-